Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism
Publication in refereed journal

替代計量分析
.

其它資訊
摘要OBJECTIVE This study examined associations of maternal glycemia during pregnancy with childhood glucose outcomes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort. RESEARCH DESIGN AND METHODS HAPO was an observational international investigation that established associations of maternal glucose with adverse perinatal outcomes. The HAPO Follow-up Study included 4,832 children ages 10-14 years whose mothers had a 75-g oral glucose tolerance test (OGTT) at similar to 28 weeks of gestation. Of these, 4,160 children were evaluated for glucose outcomes. Primary outcomes were child impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). Additional outcomes were glucose-related measures using plasma glucose (PG), A1C, and C-peptide from the child OGTT. RESULTS Maternal fasting plasma glucose (FPG) was positively associated with child FPG and A1C; maternal 1-h and 2-h PG were positively associated with child fasting, 30 min, 1-h, and 2-h PG, and A1C. Maternal FPG, 1-h, and 2-h PG were inversely associated with insulin sensitivity, whereas 1-h and 2-h PG were inversely associated with disposition index. Maternal FPG, but not 1-h or 2-h PG, was associated with child IFG, and maternal 1-h and 2-h PG, but not FPG, were associated with child IGT. All associations were independent of maternal and child BMI. Across increasing categories of maternal glucose, frequencies of child IFG and IGT, and timed PG measures and A1C were higher, whereas insulin sensitivity and disposition index decreased. CONCLUSIONS Across the maternal glucose spectrum, exposure to higher levels in utero is significantly associated with childhood glucose and insulin resistance independent of maternal and childhood BMI and family history of diabetes.
出版社接受日期29.11.2018
著者Scholtens DM, Kuang A, Lowe LP, Hamilton J, Lawrence JM, Lebenthal Y, Brickman WJ, Clayton P, Ma RC, McCance D, Tam WH, Catalano PM, Linder B, Dyer AR, Lowe WL, Metzger BE, Deerochanawong C, Tanaphonpoonsuk T, Binratkaew S, Chotigeat U, Manyam W, Forde M, Greenidge A, Neblett K, Lashley PM, Walcott D, Corry K, Francis L, Irwin JA, Langan A, McCance DR, Mousavi M, Young I, Gutierrez J, Jimenez J, Lawrence JM, Sacks DA, Takhar HS, Tanton E, Brickman WJ, Howard J, Josefson JL, Miller L, Bjaloncik J, Catalano PM, Davis A, Koontz M, Presley L, Smith S, Tyhulski A, Li AM, Ma RC, Ozaki R, Tam WH, Wong M, Yuen CSM, Clayton PE, Khan A, Vyas A, Maresh M, Benzaquen H, Glickman N, Hamou A, Hermon O, Horesh O, Keren Y, Lebenthal Y, Shalitin S, Cordeiro K, Hamilton J, Nguyen HY, Steele S, Chen F, Dyer AR, Huang WY, Kuang A, Jimenez M, Lowe LP, Lowe WL
期刊名稱Diabetes Care
出版年份2019
月份3
卷號42
期次3
出版社AMER DIABETES ASSOC
頁次381 - 392
國際標準期刊號0149-5992
電子國際標準期刊號1935-5548
語言英式英語
Web of Science 學科類別Endocrinology & Metabolism;Endocrinology & Metabolism

上次更新時間 2020-30-07 於 01:50